Cart 0 items $0.00
Generic Velpanat
Velpanat
Velpanat is an antiviral combination of sofosbuvir and velpatasvir used to treat chronic hepatitis C virus (HCV) infection across all major genotypes.
Select Doses: 400/100mg
400/100mg
56tabs
Velpanat $3494.39
$2911.99
$52.00 per tab
+ Free standard airmail service
+ Package delivery insurance
+ Next orders 10% discount
ADD TO CART
save: $168.00
400/100mg
28tabs
Velpanat $1847.99
$1539.99
$55.00 per tab
+ Free standard airmail service
+ Package delivery insurance
+ Next orders 10% discount
ADD TO CART
save: $0.00
Your order will be packed safe and secure and dispatched within 24 hours. This is exactly how your parcel will look like (pictures of a real shipping item). It has a size and a look of a regular private letter (9.4x4.3x0.3 inches or 24x11x0.7cm) and it does not disclose its contents
Country Shipping method Delivery time Price  
Delivery 14-21 days 10$ Tracking# available in 4 days
Delivery 9-14 days 30$ Tracking# available in 2 days
Shipping worldwide Confidentiality and anonymity guarantee
Safe and secure Discrete looking packages
Dispatch orders within 24 hours 100% success delivery
Testimonials Product Description
There is no review for this product at the moment, but you can be the first to add or you can read more in Testimonials Page about related products.
Add Review

Common use

Velpanat is prescribed for the treatment of chronic hepatitis C in adults. The combination of sofosbuvir (a nucleotide polymerase inhibitor) and velpatasvir (an NS5A inhibitor) works by blocking the virus’s ability to replicate and spread in the body, leading to viral clearance when taken as directed.

Dosage and direction

Velpanat is taken once daily, with or without food. Tablets should be swallowed whole. Treatment duration is typically 12 weeks but may vary depending on hepatitis C genotype, liver condition, or prior therapy. Follow your healthcare provider’s instructions carefully.

Precautions

Inform your doctor if you have a history of liver failure, hepatitis B infection, kidney disease, or if you take medications for heart rhythm issues. Patients co-infected with HBV and HCV may be at risk of HBV reactivation. Do not stop treatment without consulting your doctor.

Contraindications

Velpanat is contraindicated in individuals with known hypersensitivity to sofosbuvir, velpatasvir, or any tablet components. It should not be used with certain medications that significantly reduce velpatasvir levels.

Possible side effect

Common side effects include headache, fatigue, nausea, and insomnia. Less common but serious effects may include slow heartbeat (especially if taken with amiodarone), liver function changes, or allergic reactions. Seek medical attention for severe or unusual symptoms.

Drug interaction

Velpanat may interact with antacids, proton pump inhibitors, rifampicin, St. John’s Wort, certain anticonvulsants, and HIV medications. Some interactions may reduce effectiveness. Always inform your healthcare provider of all medications and supplements you take.

Missed dose

If you miss a dose, take it as soon as you remember. If it is almost time for the next dose, skip the missed one. Do not double the dose.

Overdose

Overdose may cause severe headache, fatigue, nausea, or general discomfort. Seek medical attention immediately if an overdose is suspected.

Storage

Store Velpanat at room temperature, away from moisture, heat, and direct sunlight. Keep it in its original bottle and out of reach of children.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.

Testimonials
Joe, Gate City
Thank you, all is well. the packaged arrived as scheduled. Thanks a ton for the help. Everything went wonderfully. I appreciate the help and outstanding customer service.
read more»
Vanessa Day, Henham, United Kingdom
I have received the order and will be playing another shortly.
read more»
News
Ebola risk raised to 'very high' in DR Congo
The head of the UN health agency says the risk in the wider region is "high", but it remains "low" at the global level.
UK scientists developing Ebola vaccine that could be ready for trials in months
The rare species of Ebola involved - known as Bundibugyo - kills around a third of those infected and has no proven vaccine yet.
The tragedy of the 'invisible killer' of the young
Bereaved families are calling for a national cardiac screening programme for over-14s
Riskiest skin cancer cases hit UK record high
The number of melanoma skin cancer cases has risen above 20,000 a year for the first time in the UK.
Shipping Option